期刊文献+

尿道瘢痕组织胶原酶活性及TIMP-1表达的研究 被引量:3

DETECTION OF COLLAGENASE ACTIVITY AND TISSUE INHIBITOR OF METALLOPROTEINASE-1 EXPRESSION LEVEL IN THE URETHRAL SCAR TISSUE/
下载PDF
导出
摘要 目的 比较正常尿道组织和尿道瘢痕组织中胶原酶活性以及金属蛋白酶组织抑制剂 - 1(TIMP- 1)的表达 ,探讨其对尿道瘢痕组织降解的影响。 方法 取手术切除的尿道狭窄段瘢痕组织和脑死亡患者的正常尿道组织各10例 ,采用 EL ISA法检测组织中胶原酶活性及逆转录 -聚合酶链反应 (RT- PCR)检测 TIMP- 1m RNA的表达。 结果 尿道瘢痕组织中胶原酶的活性为 (15 .32± 2 .2 9) U,正常尿道组织的胶原酶活性为 (2 4 .6 7± 6 .78) U,瘢痕组织的胶原酶活性低于正常尿道组织 ,差异有统计学意义 (P<0 .0 1)。与正常尿道组织比较 ,尿道瘢痕组织的 TIMP- 1表达明显升高、差异有统计学意义 (P<0 .0 5 )。 结论  TIMP- 1表达升高、胶原酶活性降低影响了尿道瘢痕组织的降解 ,可能是尿道瘢痕增生的原因之一。 Objective To find the difference between the collagenase activity and tissue inhibitor of metalloproteinase-1 (TIMP-1) expression level in normal urethral tissue and in urethral scar tissue, and to study the effect of collagenase activity and TIMP-1 expression level on the degradation of urethral scar. Methods The urethral tissues were derived from 10 human surgical specimens of urethral stricture scar and 10 human normal urethral specimens from patients with brain death. The collagenase activity was detected by ELISA assay, and the TIMP-1 mRNA level by RT-PCR. Results The collagenase activity of urethral scar tissue was (15.32±2.29) U and lower than that of normal urethral tissue (24.67±6.78) U, there was significant difference between them (P<0.01). The TIMP-1 expression level of urethral scar tissue was higher than that of normal urethral tissue, there was significant difference between them (P<0.05).Conclusion The high level of TIMP-1 expression and the low collagenase activity in urethral scar tissue may inhibit the degradation of urethral scar, and may be one of important causes of the scar tissue hyperplasia.
出处 《中国修复重建外科杂志》 CAS CSCD 2003年第6期433-435,共3页 Chinese Journal of Reparative and Reconstructive Surgery
基金 国家自然科学基金资助项目 (39970 2 75)~~
关键词 胶原酶活性 TIMP-1 金属蛋白酶组织抑制剂-1 尿道瘢痕性狭窄 检测 Urethral scar Collagenase Tissue inhibitor of metalloproteinase-1
  • 相关文献

参考文献13

  • 1付小兵.再论成纤维细胞生长因子与软组织创伤修复[J].中国修复重建外科杂志,2000,14(5):257-260. 被引量:116
  • 2武继祥,陈德英,吴宗耀.增生性瘢痕中TGF-β和胶原酶、TIMP-1 mRNA表达的定量研究[J].中华整形外科杂志,2000,16(1):34-36. 被引量:15
  • 3Chakraborty A, Eghballn M. An immunoassay for qualitative estimation of collagenase activity in mammalian tissues. Clin Biochem, 1991; 24(6):455.
  • 4Noonan KE, Beck C, Holzmayer TA, et M. Quantitative analysis of MDRl(multidrug resistance)gene expression in human tumors by polymerase chain reaction. Prol Natl Acad Sci USA, 1990; 87(18) :7 160.
  • 5Nguyen Q, Mort JS, Roughley PJ. Preferential mRNA expression of prostromelysin relative to procollagenases and in situ localization in human articular cartilage. J Clin Invest, 1992 ; 89 (4):1 189.
  • 6Ghahary A, Shen YJ, Nedelec B, et al. Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol, 1996; 106(3):476.
  • 7Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J, 1991 ; 5(8) : 2 145.
  • 8Murray JC. Keloids and hypertrophic scar. Clin Dermatol, 1994;12(1):27.
  • 9Bullen EC, Longaker MT, Updike DL, et al. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J Invest Dermatol, 1995; 104(2):236.
  • 10Wojtowicz-Praga SM, Dickson RB, Hawkins M.L Matrix metallo proteinase inhibitors. Invest New Drugs, 1997; 15(1):61.

二级参考文献8

共引文献129

同被引文献18

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部